Thursday - March 5, 2026
Study identifies potential immunotherapy strategy for early-stage prostate cancer
February 26, 2026
ROCHESTER, Minnesota, Feb. 26 [Category: BizHospital] -- The Mayo Clinic issued the following news release:

* * *

Study identifies potential immunotherapy strategy for early-stage prostate cancer

*

PHOENIX -A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products